![Kimihiko Fujisawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kimihiko Fujisawa
Fondateur chez Aqumen Biopharmaceuticals KK
Postes actifs de Kimihiko Fujisawa
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aqumen Biopharmaceuticals KK
![]() Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Directeur/Membre du Conseil | 06/08/2009 | - |
Fondateur | 04/05/2010 | - |
Historique de carrière de Kimihiko Fujisawa
Formation de Kimihiko Fujisawa
Kyushu University | Doctorate Degree |
Statistiques
Internationale
Japon | 3 |
Opérationnelle
Director/Board Member | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Aqumen Biopharmaceuticals KK
![]() Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Health Technology |
- Bourse
- Insiders
- Kimihiko Fujisawa
- Expérience